Public health campaign associated with major reduction in antibiotic use

Jun 02, 2009

A national public health campaign in France was associated with a marked reduction of unnecessary antibiotic prescriptions, particularly in children, says new research published in this week's open-access journal PLoS Medicine. The campaign, "Antibiotiques c'est pas automatique" (Antibiotics are not automatic), ran from 2002 to 2007 during the winter months when viral respiratory infections mainly occur. The campaign included an educational campaign for healthcare workers, the promotion of rapid tests for diagnosis of streptococcal infections, and a public information campaign about viral respiratory infections and about antibiotic resistance.

The researchers, led by Didier Guillemot at INSERM and Institut Pasteur in Paris, France, report that compared to the preintervention period (2000), the total number of antibiotic prescriptions per 100 inhabitants, adjusted for frequency of flu-like symptoms during the winter season, declined by more than 25% over 5 years. The decline occurred in all 22 regions of France and affected all classes of antibiotic except quinolones, say the researchers. The greatest decrease was observed among young children aged 6󈝻 years.

The authors note that because this is an ecological analysis, they cannot conclude that the campaign actually caused the reduction in antibiotic use. Other factors that may have been responsible for the observed reduction could include other initiatives in France and Belgium at the same time, or the introduction of a vaccine against Streptococcus pneumoniae during the study period.

In a commentary on the article, Benedikt Huttner and Stephan Harbarth (uninvolved in the research) say that this study "provides the largest and most sophisticated analysis published thus far correlating a nationwide public campaign to decreased antibiotic use over an extended period of time." Because reducing antibiotic use to avoid antibiotic resistance is so important, they argue, more longitudinal and modeling research to evaluate the impact of public health strategies is needed.

More information: Sabuncu E, David J, Berne`de-Bauduin C, Pe´pin S, Leroy M, et al. (2009) Significant Reduction of Antibiotic Use in the Community after a Nationwide Campaign in France, 2002. PLoS Med 6(6): e1000084. doi:10.1371/journal.pmed.1000084, medicine.plosjournals.org/perl… journal.pmed.1000084

Source: Public Library of Science (news : web)

Explore further: New treatment approved for rare form of hemophilia

add to favorites email to friend print save as pdf

Related Stories

How to treat fevers in African children up for debate

Jan 06, 2009

A new debate in the open access journal PLoS Medicine questions whether all African children with fever should be treated presumptively with antimalarial drugs, or if treatment should wait until laboratory tests confirm malari ...

Brits battle antibiotic overuse

Jan 09, 2008

Britain's health secretary announced a $5.2 million campaign against "superbugs" that asked doctors to lay off antibiotics for viral colds, coughs and flus.

Antibiotic use in infants linked to asthma

Jun 11, 2007

New research indicates that children who receive antibiotics before their first birthday are significantly more likely to develop asthma by age 7. The study, published in the June issue of CHEST, the peer-reviewed journal ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments : 0